1
|
Mano T, Britton Z and Britton T:
Anatomo-functional basis of nonmotor symptoms in Parkinson disease.
Neurology. 87:2506–2507. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Meles SK, Teune LK, de Jong BM, Dierckx RA
and Leenders KL: Metabolic Imaging in Parkinson disease. J Nuclear
Med. 58:23–28. 2017. View Article : Google Scholar
|
3
|
Cooper CA and Chahine LM: Biomarkers in
prodromal Parkinson disease: A qualitative review. J Int
Neuropsychol Soc. 22:956–967. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chiou SM, Lin YC, Lu MK and Tsai CH:
Bilateral subthalamic stimulation for advanced Parkinson disease:
Early experience at an Eastern center. Neurol Sci. 36:515–520.
2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Nowacka B, Lubinski W, Honczarenko K,
Potemkowski A and Safranow K: Ophthalmological features of
Parkinson disease. Med Sci Monit. 20:2243–2249. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Elstein D, Alcalay R and Zimran A: The
emergence of Parkinson disease among patients with Gaucher disease.
Best Pract Res Clin Endocrinol Metab. 29:249–259. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Liang HW, Huang YP and Pan SL: Parkinson
disease and risk of acute myocardial infarction: A
population-based, propensity score-matched, longitudinal follow-up
study. Am Heart J. 169:508–514. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gorska-Ciebiada M, Saryusz-Wolska M,
Borkowska A, Ciebiada M and Loba J: Plasma levels of
thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in
elderly, diabetic patients with depressive symptoms. Aging Clin Exp
Res. 28:843–851. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gettins PG and Dolmer K: The high affinity
binding site on plasminogen activator Inhibitor-1 (PAI-1) for the
low density lipoprotein receptor-related protein (LRP1) is composed
of four basic residues. J Biol Chem. 291:800–812. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Xu F, Liu H and Sun Y: Association of
plasminogen activator inhibitor-1 gene polymorphism and type 2
diabetic nephropathy. Ren Fail. 38:157–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhou X, Hendrickx ML,
Hassanzadeh-Ghassabeh G, Muyldermans S and Declerck PJ: Generation
and in vitro characterisation of inhibitory nanobodies towards
plasminogen activator inhibitor 1. Thromb Haemost. 116:1032–1040.
2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shenai MB, Patel DM, Romeo A, Whisenhunt
JD, Walker HC, Guthrie S and Guthrie BL: The relationship of
electrophysiologic subthalamic nucleus length as a predictor of
outcomes in deep brain stimulation for parkinson disease.
Stereotact Funct Neurosurg. 95:341–347. 2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Correction: Using canadian primary care
sentinel Surveillance Network data to examine depression in
patients with a diagnosis of Parkinson disease: A retrospective
cohort study. CMAJ Open. 4:E7192016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kataoka H, Tanaka N, Eng M, Saeki K,
Kiriyama T, Eura N, Ikeda M, Izumi T, Kitauti T, Furiya Y, et al:
Risk of falling in Parkinson's disease at the Hoehn-Yahr stage III.
Eur Neurol. 66:298–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yehya A, Ghuloum S, Mahfoud Z, Opler M,
Khan A, Hammoudeh S, Abdulhakam A, Al-Mujalli A, Hani Y, Elsherbiny
R and Al-Amin H: Validity and reliability of the arabic version of
the positive and negative syndrome scale. Psychopathology.
49:181–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Nunes PM, Wright AJ, Veltien A, van Asten
JJ, Tack CJ, Jones JG and Heerschap A: Dietary lipids do not
contribute to the higher hepatic triglyceride levels of
fructose-compared to glucose-fed mice. FASEB J. 28:1988–1997. 2014.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Pelletier S, Nalpas B, Alarcon R, Rigole H
and Perney P: Investigation of cognitive improvement in
alcohol-dependent inpatients using the montreal cognitive
assessment (MoCA) score. J Addict. 2016:15390962016.PubMed/NCBI
|
18
|
McIntosh S and Adams J: Anxiety and
quality of recovery in day surgery: A questionnaire study using
Hospital Anxiety and depression scale and quality of recovery
score. Int J Nurs Pract. 17:85–92. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Guimaraes-Pereira L, Costa M, Sousa G and
Abelha F: Quality of recovery after anaesthesia measured with
QoR-40: A prospective observational study. Braz J Anesthesiol.
66:369–375. 2016.PubMed/NCBI
|
20
|
Wieser MJ, Klupp E, Weyers P, Pauli P,
Weise D, Zeller D, Classen J and Mühlberger A: Reduced early visual
emotion discrimination as an index of diminished emotion processing
in Parkinson's disease?-Evidence from event-related brain
potentials. Cortex. 48:1207–1217. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hayes AF and Rockwood NJ: Regression-based
statistical mediation and moderation analysis in clinical research:
Observations, recommendations, and implementation. Behav Res Ther.
98:39–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kovacs M, Makkos A, Weintraut R, Karadi K,
Janszky J and Kovacs N: Prevalence of anxiety among hungarian
subjects with Parkinson's disease. Behav Neurol. 2017:14701492017.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Tholfsen LK, Larsen JP, Schulz J, Tysnes
OB and Gjerstad MD: Changes in insomnia subtypes in early Parkinson
disease. Neurology. 88:352–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wyman-Chick KA, Martin PK, Minár M and
Schroeder RW: Cognition in patients with a clinical diagnosis of
Parkinson disease and scans without evidence of dopaminergic
deficit (SWEDD): 2-year follow-up. Cogn Behav Neurol. 29:190–196.
2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Leroux P and Marret S: PAI-1/t-PA ratio in
cord blood: A potential index of brain haemorrhage risk in extreme
preterms. Arch Dis Child Fetal Neonatal Ed. 98:F281–F282. 2013.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Potapov O and Kmyta O: Changes of focal
and brainstem neurologic signs in patients with traumatic brain
injury and their dependence on the-675 4G/5G polymorphism in the
PAI-1 gene. Georgian Med News. 45–51. 2014.(In Russian). PubMed/NCBI
|
27
|
Knight EJ, Testini P, Min HK, Gibson WS,
Gorny KR, Favazza CP, Felmlee JP, Kim I, Welker KM, Clayton DA, et
al: Motor and nonmotor circuitry activation induced by subthalamic
nucleus deep brain stimulation in patients with parkinson disease:
Intraoperative functional magnetic resonance imaging for deep brain
stimulation. Mayo Clin Proc. 90:773–785. 2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Pallavaram S, D'Haese PF, Lake W, Konrad
PE, Dawant BM and Neimat JS: Fully automated targeting using
nonrigid image registration matches accuracy and exceeds precision
of best manual approaches to subthalamic deep brain stimulation
targeting in Parkinson disease. Neurosurgery. 76:756–765. 2015.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Wagenbreth C, Zaehle T, Galazky I, Voges
J, Guitart-Masip M, Heinze HJ and Düzel E: Deep brain stimulation
of the subthalamic nucleus modulates reward processing and action
selection in Parkinson patients. J Neurol. 262:1541–1547. 2015.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Minami Y, Horikawa K, Akiyama M and
Shibata S: Restricted feeding induces daily expression of clock
genes and Pai-1 mRNA in the heart of Clock mutant mice. FEBS Lett.
526:115–118. 2002. View Article : Google Scholar : PubMed/NCBI
|
31
|
Cho KS, Kwon KJ, Choi CS, Jeon SJ, Kim KC,
Park JH, Ko HM, Lee SH, Cheong JH, Ryu JH, et al: Valproic acid
induces astrocyte-dependent neurite outgrowth from cultured rat
primary cortical neuron via modulation of tPA/PAI-1 activity. Glia.
61:694–709. 2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Dietzmann K, von Bossanyi P, Krause D,
Wittig H, Mawrin C and Kirches E: Expression of the plasminogen
activator system and the inhibitors PAI-1 and PAI-2 in
posttraumatic lesions of the CNS and brain injuries following
dramatic circulatory arrests: An immunohistochemical study. Pathol
Res Pract. 196:15–21. 2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zervos IA, Nikolaidis E, Lavrentiadou SN,
Tsantarliotou MP, Eleftheriadou EK, Papapanagiotou EP, Fletouris
DJ, Georgiadis M and Taitzoglou IA: Endosulfan-induced lipid
peroxidation in rat brain and its effect on t-PA and PAI-1:
Ameliorating effect of vitamins C and E. J Toxicol Sci. 36:423–433.
2011. View Article : Google Scholar : PubMed/NCBI
|